Morrisville-based drug development company Liquidia Technologies shares began trading on the Nasdaq Capital Market yesterday, July 26, under the ticker symbol “LQDA,” opening at $12.45 and closing at $11.10.
NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
July 26, 2018
As founder, president and CEO of Durham-based Eppin Pharma, Michael O’Rand is pursuing a contraceptive that he says would be “a brand new choice for men and also very helpful for family planning, for men and women.”
July 26, 2018
Early- to late-stage life science companies have until July 31 to submit applications to present at the 2018 Southeast BIO Investor & Partnering Forum to be held in Atlanta November 13-14.
July 25, 2018
Cereius, Inc., a young Durham biotechnology company developing new methods to cross the well-fortified blood-brain barrier to treat cancer that has spread to the brain, has received critical reinforcements in that battle: An NCBiotech loan and $6.5 million in a Series A equity round.
July 24, 2018
Durham-based hearing technology company MED-EL USA has been granted a U.S. Food and Drug Administration clearance to market its BONEBRIDGE bone conduction hearing implant system in the United States.
July 24, 2018
Durham-based Aerie Pharmaceuticals, an ophthalmic pharmaceutical company, has reported positive developments on its regulatory and financial fronts.
July 20, 2018
Three North Carolina companies joined the prestigious list of participants in the 2018 MedTech Innovator Accelerator and Showcase programs. The Los Angeles-based non-profit is a global competition and accelerator for medical device, digital health and diagnostic companies.
July 18, 2018
Research Triangle Park-based AgBiome, which harnesses plant microbiomes to develop novel crop protection products, has secured $65 million in Series C financing.
July 17, 2018
Locus Biosciences, a fast-emerging RTP company using genetic tricks to whack drug-resistant bacteria, has acquired EpiBiome, a young California firm with a high-speed technology platform that will add even more focus to Locus.
July 12, 2018
Shareholders of Durham-based BioCryst Pharmaceuticals have rejected a January 2018 merger agreement with Pennsylvania-based Idera Pharmaceuticals, in a special vote that will keep BioCryst in the Triangle.
July 10, 2018
The North Carolina Biotechnology Center has named Mary Beth Thomas, Ph.D., to the position of senior vice president, science and business development.
July 10, 2018
KeraNetics of Winston-Salem has reached a merger agreement with Microchips Biotech of Lexington, Mass., to create a new company, Keratin Biosciences.
July 6, 2018
LabCorp, the Burlington-based diagnostics and drug-development conglomerate, will add digital workflows into its anatomic pathology services under a new collaboration with Royal Philips, a global health technology company.
July 5, 2018
Xeomin, a botulinum toxin similar to Botox that is used cosmetically to smooth frown lines between the eyebrows, is becoming an ever more versatile product for Raleigh-based Merz North America. The FDA just approved it to treat chronic sialorrhea, or excessive drooling, in adults.
July 5, 2018
North Carolina’s reputation as the global epicenter for contract research organizations (CROs) has been boosted with the Wilmington opening of an office by German CRO proinnovera GmbH.